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Abstract
The alarm cytokine interleukin-1b (IL-1b) is a potent activator of
the inflammatory cascade following pathogen recognition. IL-1b
production typically requires two signals: first, priming by recogni-
tion of pathogen-associated molecular patterns leads to the
production of immature pro-IL-1b; subsequently, inflammasome
activation by a secondary signal allows cleavage and maturation
of IL-1b from its pro-form. However, despite the important role of
IL-1b in controlling local and systemic inflammation, its overall
regulation is still not fully understood. Here we demonstrate that
peritoneal tissue-resident macrophages use an active inhibitory
pathway, to suppress IL-1b processing, which can otherwise occur
in the absence of a second signal. Programming by the transcrip-
tion factor Gata6 controls the expression of prostacyclin synthase,
which is required for prostacyclin production after lipopolysaccha-
ride stimulation and optimal induction of IL-10. In the absence of
secondary signal, IL-10 potently inhibits IL-1b processing, providing
a previously unrecognized control of IL-1b in tissue-resident
macrophages.
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Introduction
Interleukin-1b (IL-1b) is a pro-inflammatory cytokine, an alarmin
which, once released into the extracellular milieu, triggers the
inflammatory response. It is commonly accepted that a two-step
mechanism is required for IL-1b production in mouse macrophages
(MФ). First, pathogen-associated molecular pattern (PAMP) recogni-
tion induces transcription and translation of the inactive pro-form of
IL-1b (pro-IL-1b). A secondary signal, such as reactive oxygen
species (ROS) (Nakahira et al, 2011; Zhou et al, 2011), crystals
(Hornung et al, 2008) or potassium efflux (Petrilli et al, 2007), is
then needed to induce the classical inflammasome assembly,
composed of NOD-like receptor family, pyrin domain containing 3
(Nlrp3) and apoptosis-associated speck-like protein containing a
CARD (ASC), also called PYCARD. Once assembled, the NLRP3
inflammasome activates caspase1 which in turn cleaves pro-IL-1b
into its mature IL-1b form (Bryant & Fitzgerald, 2009; Dowling &
O’Neill, 2012; Latz et al, 2013; Lamkanfi & Dixit, 2014). Despite
intensive research, the mechanisms regulating IL-1b maturation and
release (Lopez-Castejon & Brough, 2011; Martin-Sanchez et al,
2016) are still under discussion (Cullen et al, 2015; Evavold et al,
2018; Monteleone et al, 2018). Dysregulated IL-1b production has
been associated with the development of many inflammatory and
autoinflammatory diseases (Lamkanfi & Dixit, 2012, 2014; Yao et al,
2016; Mayer-Barber & Yan, 2017) such as cryopyrin-associated peri-
odic syndromes (CAPS), type 2 diabetes (Jourdan et al, 2013),
increased susceptibility to Crohn’s disease (Villani et al, 2009) and
intestinal inflammation (Shouval et al, 2016), gout (Joosten et al,
2010) and rheumatoid arthritis (Pascual et al, 2005).
Macrophages are part of the immune system’s first line of
defence. Initially simply categorized as phagocytes, evidence of their
complexity has accumulated over the years (Ley et al, 2016). Resi-
dent peritoneal macrophages (pMФ), a well-studied tissue macro-
phage population, have essential functions, including modulation of
the inflammatory response after pathogen recognition (Dioszeghy
et al, 2008; Spight et al, 2008; Leendertse et al, 2009) or injury
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(Uderhardt et al, 2019), phagocytosis of pathogens (Ghosn et al,
2010) and dying cells (Fond & Ravichandran, 2016), liver repair
(Wang & Kubes, 2016; Rehermann, 2017) and maintenance of self-
tolerance (Russell & Steinberg, 1983; Mukundan et al, 2009; Munoz
et al, 2010; Uderhardt et al, 2012; Ipseiz et al, 2014; Majai et al,
2014; Carlucci et al, 2016). pMФ are part of the first wave of
response during peritonitis (Khameneh et al, 2017) and help ensure
the survival of the host and the optimal clearance of the infection.
Their efficiency is coupled to their optimal cytokine and chemokine
secretion which have to be finely tuned, including IL-1b (Topley
et al, 1996; Hautem et al, 2017). After the first inflammatory burst
following PAMP recognition, macrophages dampen their inflamma-
tory processes by producing anti-inflammatory molecules, such as
IL-10 (Bogdan et al, 1991; Berlato et al, 2002; Saraiva & O’Garra,
2010). IL-10 protects against acute inflammation (Howard et al,
1993), and its loss has dramatic effects as observed in IL-10 deficient
mice, which develop chronic enterocolitis (Kuhn et al, 1993; Krause
et al, 2015). However, the regulatory control of IL-10 production by
pMФ (Liao et al, 2016) as well as its mode of action remain unclear.
Additionally, after microbial stimulation, peritoneal macrophages
rapidly release prostanoids, such as prostaglandin I2 (PGI2), also
called prostacyclin (Brock et al, 1999). PGI2 is known to be gener-
ated in peritoneal macrophages following inflammatory stimulation,
although it is poorly studied and neglected in this context (Yokode
et al, 1988; Stewart et al, 1990; Wightman & Dallob, 1990). Despite
the paradoxical role of PGI2 in inflammatory diseases (Stitham et al,
2011), synthetic analogues can decrease tumour necrosis factor
(TNF) and induce IL-10 in human peripheral mononuclear cells
in vitro (Eisenhut et al, 1993; Luttmann et al, 1999) and inhibit
function of murine dendritic cells (Zhou et al, 2007), suggesting an
active control of inflammation.
Here we have studied the inflammatory response of resident
pMФ that lack their specialized tissue-programming as a conse-
quence of deletion of the tissue-specific transcription factor Gata6
(Rosas et al, 2014). While wild-type (WT) pMФ need a secondary
signal after lipopolysaccharide (LPS) stimulation to produce mature
IL-1b, we show that the Gata6-deficient pMФ do not, and they
exhibit aberrant production of IL-1b after LPS stimulation. Using
Gata6-KOmye pMФ, we identified a Gata6-PGI2-IL-10 axis as a major
regulator of IL-1b processing in resident pMФ. This axis actively
inhibits IL-1b processing during response to a microbial stimulus in
the absence of a second signal and thus ensures proportionate and
finely regulated production of IL-1b in response to LPS.
Results
Gata6-deficient peritoneal macrophages exhibit dysregulated
IL-1b release
We and others previously identified the transcription factor Gata6
as a major key regulator of tissue-resident peritoneal macrophage
(pMФ) specialization (Gautier et al, 2014; Okabe & Medzhitov,
2014; Rosas et al, 2014). To determine its role in the inflammatory
function of pMФ, we analysed the response of Gata6-WT and
Gata6-KOmye pMФ after toll-like receptor (TLR) ligand stimulation.
Surprisingly, we observed that ultra-pure LPS, a specific TLR4
agonist, induced the production of IL-1b by Gata6-KOmye pMФ in
the absence of an exogenous secondary signal (Fig 1A). LPS also
induced significantly higher production of TNF by Gata6-KOmye
pMФ as observed by ELISA (Fig 1B) and flow cytometry (Figs EV1
and 2A). Additionally, the effect of LPS on IL-1b and TNF produc-
tion was found to be concentration (Fig 1C and D) and time-
dependent (Fig 1E and F). Interestingly, inhibiting TNF with etan-
ercept (a fusion protein composed of TNFR2 connected to a
human IgG1 Fc tail) slightly reduced IL-1b production from Gata6-
KOmye pMФ and blocking the IL-1 signalling pathway using an IL-
1 receptor antagonist (rIL-1ra) when stimulating the cells with
purified LPS did not dramatically change IL-1b secretion by Gata6-
WT or Gata6-KOmye pMФ (Fig 1G). Stimulating the cells with
recombinant TNF (recTNF) did not induce IL-1b production from
either Gata6-WT or Gata6-KOmye pMФ (Fig 1H). These data
suggest that neither IL-1 receptor nor TNF signalling greatly
affected IL-1b production.
Activation of the NLRP3 inflammasome by classical stimuli is
independent of Gata6 programming
To investigate the mechanism behind the aberrant release of IL-1b
by Gata6-KOmye pMФ following LPS stimulation, we analysed the
components of the classical NLRP3 inflammasome pathway. Gata6-
WT and KOmye pMФ showed similar levels of toll-like receptors
(Tlr) expression, with an exception for Tlr13 which appeared to be
reduced in Gata6-KOmye cells. Tlr4 and Cd14, the receptor and co-
receptor, respectively, for LPS were similarly expressed by Gata6-
WT and KOmye cells (Fig 2A). Cell surface expression analysis by
flow cytometry however showed an increase in TLR2 and TLR4 in
KOmye cells (Figs 2B and EV2B). Gata6-WT and KOmye pMФ exhib-
ited similar Il1b mRNA expression (Fig 2C) and comparable
production of pro-IL-1b (Figs 2D and EV3A), 3 and 6 h after LPS
stimulation, respectively. Interestingly, Gata6-KOmye cells showed a
significantly upregulated Tnf expression (Fig 2C), indicating a
direct regulation of TNF production on a mRNA level rather than
on a protein level. The pro-IL-1b expression was confirmed by flow
cytometry analysis (Fig 2E). These results suggest that, despite an
increased TLR4 expression in Gata6-KOmye pMФ, both Gata6-WT
and KOmye pMФ have a similar response capacity to the primary
signal LPS regarding the initiation of IL-1b production and that the
aberrant release observed in the Gata6-KOmye cells was likely due
to a downstream dysregulation in pro-IL-1b processing. Further
investigation revealed that Gata6-KOmye pMФ did not have
increased Nlrp3 mRNA expression compared to WT pMФ (Fig 2F),
as well as similar protein levels (Figs 2G and EV3B). To determine
whether the classical Nlrp3 inflammasome was responsible for the
IL-1b release in Gata6-KOmye pMФ, we stimulated Gata6-WT and
KOmye pMФ with LPS in the presence of the specific Nlrp3 inhi-
bitor MCC950 (Coll et al, 2015, 2019). We observed an abrogation
of IL-1b secretion from Gata6-KOmye cells (Fig 2H and I), con-
firming the essential role of Nlrp3 in the production of IL-1b by
Gata6-KO pMФ. In addition, Gata6-KOmye cells showed upregulated
mRNA expression of caspase1 (Casp1) (Fig 2J) but protein expres-
sion showed no significant difference (Figs 2K and EV3C). The
selective caspase1 inhibitor Ac-YVAD-cmk blocked IL-1b secretion
by LPS-stimulated Gata6-KOmye pMФ (Fig 2L). Interestingly, when
first primed with LPS for 3 h and then stimulated with a secondary
signal (ATP or nigericin) for 30 min, both Gata6-WT and KOmye
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pMФ released comparable levels of IL-1b (Fig 2M). Confocal
immunofluorescence analysis showed that both cell types were
able to form ASC specks, a hallmark of the classical NLRP3
inflammasome assembly, when stimulated with LPS and ATP
(Fig 2N). Overall, these data indicate a similar NLRP3 inflamma-
some capacity of both Gata6-WT and KOmye pMФ, suggesting that
the aberrant IL-1b release observed in Gata6-KOmye cells after LPS
stimulation might be due to alteration of the regulatory mecha-
nisms and not to the inflammasome machinery itself.
Peritoneal-resident macrophages actively suppress
IL-1b production
Based on our findings above, we next hypothesized that the Gata6-
KOmye pMФ had a defect in an inhibitory pathway, present in the
Gata6-WT cells, that basally constrains further processing of pro-
IL-1b after LPS stimulation. To investigate this hypothesis, we co-
cultured Gata6-WT and KOmye cells and observed a nearly complete
inhibition of IL-1b secretion by the Gata6-KOmye pMФ (Fig 3A). This
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observation suggested that the Gata6-WT cells actively inhibited IL-
1b processing by the Gata6-KOmye pMФ. To determine whether this
inhibition was due to direct contact between the cells or to a soluble
factor secreted by the Gata6-WT pMФ, we performed a Transwell
experiment (Fig 3B). In this setting, the Gata6-WT pMФ signifi-
cantly inhibited IL-1b production from the Gata6-KOmye pMФ,
however to a lesser extent than in the direct co-culture experiments.
These data may suggest that the Gata6-WT pMФ might be secreting
a soluble molecule, albeit with a short half-life based on the reduced
effect observed in the Transwell setting, inhibiting the pro-IL-1b
processing pathway. Transcriptomic analysis of Gata6-WT and
Gata6-KOmye pMФ (Rosas et al, 2014) showed alterations in many
such potential candidate molecules (GEO: GSE47049); however, one
of the greatest differentially expressed genes was prostaglandin I2
synthase (Ptgis) which converts prostaglandin H2 (PGH2) into
prostacyclin (PGI2). Naı¨ve Gata6-KOmye pMФ expressed signifi-
cantly reduced amount of Ptgis mRNA (Fig 3C) and protein (Fig 3D)
and significantly upregulated thromboxane A synthase 1 (Tbxas1)
(Fig 3C), a direct competitor to Ptgis for the conversion of PGH2
into thromboxane A2 (TXA2). The expression of the two other
enzymes implicated in the processing pathway of arachidonic acid
(AA), cyclooxygenase 1 (Ptgs1) converting AA into prostaglandin
G2 (PGG2) followed by PGH2 and prostaglandin E synthase 2
(Ptges2) processing PGH2 into prostaglandin E2 (PGE2) was less
dramatically changed between Gata6-WT and Gata6-KOmye pMФ
(Fig 3C). PGI2 has a very short half-life (< 2 min in vivo) and is
rapidly hydrolysed to form 6-keto-prostaglandin F1a (6-keto-
PGF1a), a metabolite that is readily detectable by mass spectrometry
(Kunze & Vogt, 1971; Hamberg & Samuelsson, 1973; Jogee et al,
1983; Lewis & Dollery, 1983; Stitham et al, 2011). Therefore, to
assess the impact of the Ptgis deficiency in Gata6-KOmye cells on
prostanoid production, we performed mass spectrometric analysis
of the oxylipins in supernatants from Gata6-WT and KOmye pMФ
cultured with or without 100 ng/ml LPS for 3 h. As expected, a
significant reduction of 6-keto-PGF1a coupled with increased throm-
boxane B2 (TXB2) was observed from Gata6-KOmye pMФ after LPS
stimulation (Fig 3E). Notably, prostaglandin E2 (PGE2) was also
significantly decreased in Gata6-KOmye pMФ after LPS stimulation
although the expression of the enzyme regulating its production
(Ptges2) was unchanged (Fig 3C). These results confirmed an imbal-
anced prostanoid response in Gata6-KOmye cells upon LPS stimula-
tion (Fig 3F). It is important to note that both TXB2 and PGE2 were
produced at much lower levels when compared to 6-keto-PGF1a, in
WT LPS-stimulated cells (approximately 10% of the levels). This
suggests that PGI2 may normally be the dominant effector on down-
stream signalling in pMФ (Norris et al, 2011). Altogether, these data
suggest that Gata6-WT pMФ are actively inhibiting the processing of
IL-1b upon LPS stimulation and that a candidate for this effect may
be PGI2 produced by the Gata6-dependent Ptgis enzyme.
Prostacyclin inhibits IL-1b production via IL-10 induction in a
Gata6-dependant pathway
PGI2 and LPS have both been previously shown to induce IL-10
production, including in MФ (Fiorentino et al, 1991; Luttmann et al,
1999; Zhou et al, 2007). It is also known that pMФ are predisposed
to the production of IL-10 after stimulation with microbial products
(Liao et al, 2016). Here, we observed that Gata6-KOmye pMФ
produced significantly less IL-10, compared to Gata6-WT cells, after
LPS stimulation (Fig 4A). To determine if this could be a conse-
quence of reduced PGI2 levels, the impact of beraprost, cicaprost
and iloprost (PGI2 analogues with various IP receptor affinities and
specificities; Clapp & Gurung, 2015) on IL-10 generation was
assessed (Fig 4B). When combined with LPS, all three analogues
significantly increased IL-10 production in Gata6-KOmye pMФ
(Fig 4B) compared to LPS and vehicle control (DMSO). In addition,
all three analogues inhibited IL-1b production from Gata6-KOmye
pMФ (Fig 4C). These data indicate that LPS-mediated induction of
IL-10 in pMФ is driven via a Gata6-PGI2-dependent pathway that, in
turn, controls IL-1b production. As beraprost has been previously
shown to have the most specific binding to IP receptor (Clapp &
Gurung, 2015), we chose to conduct further experiments with this
agonist only. Given the general imbalance in prostanoid content in
Gata6-KOmye pMФ, we wondered if other prostanoids could also
play a similar role in the control of IL-10 and IL-1b in pMФ. To test
this hypothesis, we stimulated the cells with beraprost, PGE2,
U46619 (TXA2 receptor agonist) and picotamide (TXA2 receptor
and Tbxas1 inhibitor) and analysed their IL-10 and IL-1b production
(Fig 4D and E). PGE2 was able to induce IL-10 at a similar level to
beraprost in Gata6-KOmye pMФ (Fig 4D) and also block IL-1b
production (Fig 4E). However, neither U46619 nor picotamide
affected IL-10 or IL-1b production in LPS-stimulated cells. These
results indicate that prostanoid balance, especially the prevalence of
PGE2 and PGI2 in pMФ, controls the activation status of the cells
and their response to inflammatory stimuli such as LPS. To investi-
gate if the reduced amount of PGI2-derived IL-10 in Gata6-KOmye
◀ Figure 1. Aberrant cytokine release from LPS-stimulated Gata6-deficient resident peritoneal macrophages.A, B Gata6-WT and Gata6-KOmye peritoneal macrophages (pMФ) were unstimulated (–) or stimulated with TLR2L Pam3CSK4 (500 ng/ml), TLR3L Poly(I:C) (1 lg/ml),
TLR4L ultrapure LPS (100 ng/ml), TLR5L flagellin (100 ng/ml), TLR7 and 8L R848 (1 lg/ml) or TLR9L CpG ODN1826 (5 lM). Culture supernatants were collected 24 h
after the start of stimulation and IL-1b and TNF ELISA were performed. n = 5, two-way ANOVA analysis with Tukey’s multiple comparison post-test.
C, D IL-1b (C) and TNF (D) ELISA of Gata6-WT and Gata6-KOmye pMФ stimulated for 24 h with the indicated LPS concentrations. n = 3, two-way ANOVA analysis with
Sidak’s multiple comparison post-test.
E, F IL-1b (E) and TNF (F) ELISA from Gata6-WT and Gata6-KOmye pMФ stimulated with LPS (100 ng/ml) for the indicated times. n = 3, two-way ANOVA analysis with
Sidak’s multiple comparison post-test.
G IL-1b ELISA of Gata6-WT and Gata6-KOmye pMФ stimulated for 18 h with 100 ng/ml LPS or recombinant IL-1 receptor antagonist (rIL-1ra), n = 4–5, two-way
ANOVA analysis with Tukey’s multiple comparison post-test.
H IL-1b ELISA of Gata6-WT and Gata6-KOmye pMФ stimulated for 18 h with 100 ng/ml LPS or 100 ng/ml recombinant TNF (recTNF), n = 4–5, two-way ANOVA
analysis with Tukey’s multiple comparison post-test.
Data information: Data are expressed as mean  SEM. *P < 0.05, **P < 0.01, ***P < 0.001.
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pMФ was responsible for their aberrant IL-1b production, we stimu-
lated the cells with either beraprost or IL-10 together with LPS. Both
beraprost and IL-10 significantly reduced the IL-1b production from
Gata6-KOmye cells after LPS stimulation, to levels that were compa-
rable to those of the WT cells (Fig 4F). Lastly, we incubated the
cells with an anti-IL-10 receptor (aIL-10R) neutralizing antibody, or
an isotype-matched control, together with LPS and beraprost. As
expected, the blockade of the IL-10 receptor, and thereby its signal-
ling pathway, completely abrogated the effect of beraprost on IL-1b
release (Fig 4G). Strikingly, IL-10R-inhibition, in the absence of any
exogenous second signal, resulted in IL-1b production from Gata6-
WT cells that was comparable to aberrant behaviour of Gata6-defi-
cient counterparts. Together, these data demonstrate that WT cells
actively block IL-1b production via a Gata6-PGI2-IL-10-dependent
pathway, that is induced by LPS stimulation. To further understand
the mechanism regulating this pathway, we performed a similar
experiment, including the MCC950 inhibitor. When combined with
aIL-10R treatment, MCC950 still inhibited the production of IL-1b
after LPS stimulation, but only in Gata6-KOmye pMФ (Fig 4H),
which coincided with a decrease in IL-10 production from these cells
(Fig 4I). Notably, MCC950 had no effect on IL-1b and IL-10 produc-
tion from Gata6-WT cells incubated with aIL-10R and LPS compared
to aIL-10R and LPS-stimulated cells. These data suggest that the
blockade of the IL-10 pathway in Gata6-WT pMФ activates alterna-
tive pathways leading to increased stress and production of IL-1b in
a non-canonical Nlrp3-independent pathway, in the absence of a
secondary signal. As IL-10 had such a potent effect on IL-1b produc-
tion in pMФ after primary stimulation, we wondered if it could also
affect IL-1b production in the presence of a secondary signal. We
incubated Gata6-WT and Gata6-KOmye pMФ with LPS and IL-10 for
16 h, followed by a 30 min pulse with ATP. IL-10 was sufficient to
significantly inhibit IL-1b production from both Gata6-WT and
KOmye cells (Fig 4J), consistent with its major role in the control of
inflammation.
Deficiency in Gata6 does not lead to dysfunctional mitochondria
Previous work has shown that IL-10 is essential to maintain mito-
chondria integrity in bone-marrow-derived macrophages (BMDM)
(Ip et al, 2017). IL-10-deficient BMDM accumulate ROS which is
known to activate NLRP3 inflammasome assembly leading to IL-1b
production (Zhou et al, 2011). To investigate whether the aberrant
IL-1b production we observed was mediated by mitochondrial
dysfunction, we first analysed the mitochondrial membrane poten-
tial (MMP) and mitochondrial mass from Gata6-WT and KOmye
pMФ in vivo by intraperitoneal injection of MitoTracker Green (MT
green, total mitochondrial mass, independent of MMP) and Mito-
Tracker Red (MT red, live mitochondria, dependent on MMP) to
naı¨ve mice before harvesting the peritoneal cells (Fig 5A). Both
Gata6-WT and Gata6-KOmye mitochondria showed similar mito-
chondrial mass characterized by a similar MT green staining but the
Gata6-KOmye pMФ had significantly more MMP characterized by an
increased MT red staining. We then investigated the effect of LPS,
IL-10 and aIL-10R antibody on the mitochondria by performing
in vitro experiments (Fig 5B). Unstimulated Gata6-KOmye pMФ had
a significantly higher amount of mitochondrial mass and respiring
mitochondria; however, addition of LPS reduced this phenotype to
that of Gata6-WT pMФ level. Inhibition of IL-10 signalling using
aIL-10R resulted in lower mitochondrial mass of Gata6-WT pMФ
stimulated with LPS compared to Gata6-KOmye cells. No significant
difference in MMP could be observed between Gata6-WT and
Gata6-KOmye pMФ (Fig 5B, right). Altogether, these data confirmed
that deletion of Gata6 was not detrimental to mitochondria health,
in naı¨ve or LPS-stimulated pMФ. In addition, staining with
MitoSOX, a mitochondria-specific ROS indicator, showed that
Gata6-WT and KOmye pMФ produced similar levels of superoxide
(Fig 5C), regardless of the stimulation. To confirm that mitochon-
drial ROS were not implicated in the aberrant IL-1b production
observed in the Gata6-KOmye pMФ, we treated the cells with the
◀ Figure 2. The aberrant release of IL-1b by Gata6-KO-deficient pMФ follows classical inflammasome activation.A Normalized expression of Tlr and Cd14 genes following microarray analysis performed on unstimulated cell-sorted Gata6-WT and Gata6-KOmye pMФ. Data are
shown as mean  SEM from three biological replicates. Statistical significance was determined using empirical Bayesian statistic corrected for false discovery rate
by the Benjamini–Hochberg procedure. n.d = non-detectable.
B Mean fluorescence intensity (MFI) of extracellular TLR2, TLR4 and CD14 expression on naïve Gata6-WT and Gata6-KOmye pMФ. n = 4–7 individual mice per group.
C, D Il1b and Tnf mRNA relative expression (C) and IL-1b Western blot protein analysis (D) of Gata6-WT and Gata6-KOmye pMФ stimulated with 100 ng/ml LPS for 3 and
6 h respectively. Data shown are representative of at least three independent experiments. Western blot was performed on whole cell lysates.
E Representative dot plot, percentage and mean fluorescence intensity (MFI) analysis of pro-IL-1b+ Gata6-WT and Gata6-KOmye pMФ flow cytometry analysis 3 h
after stimulation with 100 ng/ml LPS. n = at least three independent experiments.
F Nlrp3 mRNA relative expression of Gata6-WT and Gata6-KOmye pMФ stimulated with 100 ng/ml LPS for 3 h. Data shown are pooled from three independent
experiments.
G Western blot protein analysis of Gata6-WT and Gata6-KOmye pMФ stimulated with 100 ng/ml LPS for 6 h. Data shown are representative of at least three
independent experiments. Western blot was performed on whole cell lysates.
H, I IL-1b ELISA (H) and Western blot protein analysis (I) of supernatants collected from Gata6-WT and Gata6-KOmye pMФ stimulated with 100 ng/ml LPS and either
vehicle control (Vh, DMSO) or 10 lM MCC950 for 24 h (n = 5). Data shown in (H) are pooled from five independent replicates.
J, K Caspase1 (Casp1) mRNA relative expression (J) and Western blot protein analysis (K) of Gata6-WT and Gata6-KOmye pMФ stimulated with 100 ng/ml LPS for 3 and
6 h respectively. Data shown are pooled from three independent experiments.
L IL-1b ELISA of Gata6-WT and Gata6-KOmye pMФ stimulated with 100 ng/ml LPS and either vehicle control (Vh, DMSO) or Ac-YVAD-cmk for 24 h. Data shown are
pooled of five independent replicates.
M IL-1b ELISA of Gata6-WT and Gata6-KOmye pMФ stimulated with 100 ng/ml LPS for 3 h, followed by a 30 min pulse with either vehicle control (Vh), 5 mM ATP or
20 lM nigericin. Data shown are pooled of five independent replicates.
N Representative picture of confocal immunofluorescence analysis of Gata6-WT and Gata6-KOmye pMФ stimulated with 100 ng/ml LPS for 3 h, followed by a 30 min
pulse with 5 mM ATP. The white arrows show ASC specks. Scale bar = 10 lm.
Data information: Data are expressed as mean  SEM and analysis were performed using two-way ANOVA analysis Tukey’s multiple comparison post-test unless
otherwise stated. *P < 0.05, **P < 0.01, ***P < 0.001.
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antioxidants MitoTEMPO, N-acetyl-L-cysteine (NAC) and mito-
quinone (MitoQ) together with LPS and analysed their IL-1b produc-
tion. All three antioxidants were unable to inhibit IL-1b production
from Gata6-KOmye cells (Fig 5D), confirming that mitochondrial
ROS were not responsible for IL-1b production by Gata6-KOmye
pMФ.
PGI2-derived IL-10 controls IL-1b processing
IL-10 has been reported to control the production of pro-inflamma-
tory cytokines, such as TNF, by inhibiting their transcription (Mur-
ray, 2005). Here, to investigate how the PGI2-derived IL-10
regulates IL-1b in pMФ in the absence of a secondary signal, we
stimulated Gata6-WT and KOmye pMФ with beraprost, IL-10, aIL-
10R or isotype control together with LPS for 3 h and analysed Il1b
mRNA expression. IL-10 only slightly downregulated Il1b expression
(Fig 6A) and aIL-10R increased it, most notably in Gata6-WT cells.
In the presence of LPS, beraprost and IL-10 did not significantly
affect Nlrp3 or Casp1 expression. However, when combined with
LPS, aIL-10R significantly increased Nlrp3 mRNA expression in both
Gata6-WT and KOmye pMФ, compared to LPS and isotype-matched
control. The treatments had no significant effect on Casp1 expres-
sion, except for a small but significant downregulation induced by
beraprost alone. Downstream analysis revealed that the protein
level of the inflammasome components also remained quite stable
following the various treatments (Fig 6B). LPS stimulation of Gata6-
WT and KOmye pMФ for 6 h strongly induced pro-IL-1b and Nlrp3
protein level, and co-stimulation with IL-10 repeatedly decreased
them. The various treatments did not dramatically affect caspase1
or ASC protein level, although it is interesting to note that ASC
protein level showed strong variation between experiments.
Caspase1 activity was evaluated using the FAM FLICA reagent on
cells stimulated for 16 h. Gata6-KOmye pMФ showed a significant
increase in caspase1 activity compared to Gata6-WT cells, indepen-
dently of the stimulation (Fig 6C). LPS further increased caspase1
activity in Gata6-KOmye pMФ, and this could not be rescued by any
other additional stimulation. Thorough analysis of pro-IL-1b by flow
cytometry confirmed that LPS induced pro-IL-1b production in both
Gata6-WT and KOmye pMФ and that co-stimulation with IL-10
decreased it in WT cells (Figs 6D and EV4B), in accordance with the
mRNA and Western blot data. Blockade of the IL-10 pathway with
aIL-10R increased pro-IL-1b, as observed on mRNA. Overall, these
data indicate a direct regulation of pro-IL-1b and Nlrp3 mRNA and
protein synthesis via an IL-10-dependent pathway in pMФ. It is
interesting to note that a short time in vitro culture of pMФ (16 h)
was sufficient to strongly affect the baseline production of pro-IL-1b.
Indeed, we could not detect any pro-IL-1b in freshly isolated and
stained cells, compared to cells cultured unstimulated for 16 h
(Figs 6D and EV4A and 5B). Despite all precautions taken to ensure
optimal cell culture and minimizing activation of the cells, both
Gata6-WT and Gata6-KOmye pMФ cultured for 16 h showed elevated
pro-IL-1b content, compared to freshly isolated cells. This could, in
part, explain the variation observed between samples and experi-
ments. It is interesting to note that when challenged with LPS,
Gata6-WT and KOmye mice showed similar neutrophil recruitment
to their peritoneal cavity (Fig EV5A) and increased pro-IL-1b
content in pMФ (Fig EV5B) as well as an increased IL-1b content in
the peritoneal fluid, the latter of which was higher in the Gata6-
KOmye mice than the Gata6-WT mice (Fig EV5C). Although previous
work have shown that IL-1b can directly modulate neutrophil
recruitment (Martinon et al, 2006), it does not seem to be the case
in our model. This discrepancy could possibly be explained by the
fact that the defect we observe is localized to a single-cell popula-
tion, which is reduced in number. Additionally, preliminary
attempts to regulate neutrophil recruitment with anakinra had no
effect (Fig EV5D). Further in vitro analyses showed that LPS upregu-
lated Il10 expression in Gata6-WT pMФ but to a much lower extent
in Gata6-KOmye cells (Fig 6E). Interestingly, the addition of bera-
prost to LPS stimulation rescued Il10 expression in Gata6-KOmye
cells, confirming the essential role of PGI2 in the induction of Il10 in
pMФ after LPS stimulation. Direct stimulation with IL-10 was not
able to rescue the Il10 expression in Gata6-KOmye pMФ, suggesting
that, in this setting, IL-10 does not control its own transcription.
However, blocking IL-10 signalling using aIL-10R boosted Il10
expression in Gata6-WT pMФ stimulated with LPS, underlying the
fact that IL-10 is an essential response to LPS stimulation and is at
least partially dependent on PGI2. In contrast, Tnf expression in
Gata6-KOmye pMФ after LPS stimulation was significantly downreg-
ulated by co-treatment with beraprost or IL-10 and aIL-10R antibody
strongly induced Tnf expression in both Gata6-WT and Gata6-KOmye
cells (Fig 6E), indicating a direct transcriptional regulation of Tnf
expression. Overall, these results show a clear differential regulation
of classical pro-inflammatory cytokines production, such as TNF,
and IL-1b production in pMФ. PGI2-derived IL-10 at least partially
◀ Figure 3. Prostanoid production is imbalanced in Gata6-KOmye pMФ.A IL-1b ELISA analysis of supernatants of Gata6-WT and Gata6-KOmye pMФ in monoculture or co-cultured (ratio 1:1) and stimulated for 24 h with 100 ng/ml LPS. Data
shown are pooled from three independent experiments. One-way ANOVA statistical analysis with Tukey’s multiple comparison test was performed.
B IL-1b ELISA analysis of supernatants of Gata6-WT and Gata6-KOmye pMФ co-cultured in the same well (co-culture) or using Transwell system (ratio 1:1) and
stimulated for 24 h with 100 ng/ml LPS. Data shown are pooled from three independent experiments. One-way ANOVA statistical analysis with Tukey’s multiple
comparison test was performed.
C Microarray analysis of Ptgis, Tbxas1, Ptges2 and Ptgs1 expression from Gata6-WT and Gata6-KOmye pMФ isolated from naïve mice. Data are shown as mean  SEM
from three biological replicates. Statistical significance was determined using empirical Bayesian statistic corrected for false discovery rate by the Benjamini–
Hochberg procedure.
D Western blot analysis of Ptgis protein level of unstimulated pMФ from Gata6-WT and Gata6-KOmye mice.
E Mass spectrometry analysis of 6-keto-PGF1a, TXB2 and PGE2 content of Gata6-WT and Gata6-KOmye pMФ unstimulated (–) or stimulated for 3 h with 100 ng/ml LPS.
n = 6. Two-way ANOVA statistical analysis with Tukey’s multiple comparison post-test was performed.
F Representation of the variation of the prostanoid synthesis pathway in Gata6-KOmye pMФ created using Cytoscape software. Circle shape represent lipids, diamond
shape enzymes, yellow downregulation and purple upregulation of the expression/production in Gata6-KOmye cells. The size of the circles represents relative levels
observed in Gata6-KOmye cells.
Data information: Data is shown as mean  SEM. *P < 0.05, **P < 0.01, ***P < 0.001.
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impairs the production of pro-IL-1b and Nlrp3 but not caspase1 nor
ASC. Our data suggest that pMФ possess an active inhibitory mecha-
nism able to tightly control IL-1b processing in the absence of
secondary signal. This inhibitory pathway not only regulates pro-IL-
1b production but also maturation and possibly its subsequent
processing (Fig 6F).
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Discussion
Our study here shows that, in the absence of secondary signal, WT
tissue-resident pMФ actively block IL-1b processing via a Gata6-
PGI2-IL-10-dependent pathway. The absence of this inhibitory path-
way leads to a significant production of IL-1b, as observed in the
Gata6-KOmye tissue-resident pMФ or when using aIL-10R antibody
in Gata6-WT pMФ. IL-1b production and secretion is a complex
mechanism, still partially uncharacterized. Upon LPS stimulation,
the immature pro-IL-1b form accumulates and its processing is
restricted, unless permitted by a secondary signal. The role of IL-1b
as an alarmin makes it an extremely potent cytokine, whose produc-
tion must be tightly controlled to avoid unnecessary inflammatory
damage to the surrounding area. The concept of specific mecha-
nisms restraining activation of the inflammasome in the absence of
secondary signal therefore seems essential. Recent work showed
that tissue MФ actively attempt to suppress inflammation and that
pMФ promote local injury repair (Wang & Kubes, 2016; Uderhardt
et al, 2019). Our work provides a mechanism for constraint of pro-
inflammatory responses at the cellular level, both autocrine and
paracrine, supporting the idea that upon pro-inflammatory signal
recognition, tissue-resident pMФ are programmed to first control
and dampen inflammation. In the presence of a secondary insult,
such as in our case inflammasome-activating molecules, this first
controlling response may be over-ruled and pMФ would then
actively promote inflammation by the release of alarmins such as
IL-1b and recruitment of neutrophils (Martinon et al, 2006).
The fact that the active inhibitory mechanism we describe here
has not been previously reported is likely explained by the lack of
tools to study IL-1b regulation. Although genetic defects leading to
spontaneous IL-1b secretion by MФ have been reported (Saitoh
et al, 2008; Vince et al, 2012; Duong et al, 2015), its maturation and
release are usually investigated in the presence of highly potent
secondary signals such as ATP and nigericin.
Previous work (Ip et al, 2017) has shown that deficiency in IL-10
in BMDM leads to dysfunctional mitochondria releasing mitochon-
drial ROS which act as a secondary signal, activating the inflamma-
some and leading to the aberrant release of IL-1b. Our results
clearly show that although Gata6-KOmye pMФ produce a much
lower amount of PGI2-derived IL-10 compared to Gata6-WT pMФ,
their mitochondria remain healthy and functional upon LPS
stimulation. This discrepancy can first be explained by the fact that
different types of MФ have been used (BMDM versus tissue-resident
pMФ). Previous work (Norris et al, 2011) showed that BMDM and
pMФ differently utilize the enzymes implicated in the AA pathway
and thereby produce differential amount of prostanoids. Upon TLR4
activation, pMФ synthesize PGI2, among others, while BMDM do
not, due to the absence, or really low expression of Ptgis. Our
results clearly show a strong preference for PGI2 production in
pMФ, approximately 10-fold higher levels of PGI2 are produced than
PGE2. When comparing tissue-resident pMФ, BMDM, thioglycolate-
induced inflammatory peritoneal MФ and RAW 264.7 MФ cell line,
the authors showed that tissue-resident pMФ had the highest
expression of Ptgis. Altogether, these data suggest that depending
on their origin, MФ differentially respond to TLR4 stimulation by
favouring the production of specific prostanoid species. Their
response to TLR4 ligand should therefore not be directly compared,
at least from a prostanoid synthesis point of view. Next, it is impor-
tant to note that the Gata6-KOmye pMФ are still able to produce
some IL-10 (about 3–4 times less than Gata6-WT pMФ) after LPS
stimulation, whereas Ip and colleagues (Ip et al, 2017) used IL-10-
deficient MФ. IL-10 is known to play an important role in homeosta-
sis (Shouval et al, 2014; Zigmond et al, 2014; Girard-Madoux et al,
2016), inflammation regulation (Mosser & Zhang, 2008) and tissue
regeneration (Siqueira Mietto et al, 2015) and a complete loss of IL-
10 could explain cell instability and mitochondria dysfunction. The
amount of IL-10 produced must be finely tuned, and although a
small amount seems to be sufficient for tissue-resident pMФ mito-
chondria health, it is less effective for IL-1b regulation.
It is interesting to note that blockade of the IL-10 signalling path-
way using aIL-10R antibody induced both mRNA and protein
expression of IL-1b and Nlrp3, suggesting that a complete blockade
of the signalling pathway directly affects IL-1b and inflammasome
components production and that the small amount of IL-10 still
produced in Gata6-KOmye pMФ is sufficient to avoid this direct
impact.
We also show that PGI2-derived IL-10 inhibits the production of
both classically produced cytokines such as TNF and IL-1b but via
two completely different mechanisms, TNF being inhibited directly
at the mRNA level and IL-1b during a later stage of processing.
These data point out that the anti-inflammatory effect of IL-10 is
dependent on its target and emphasizes the fact that careful
◀ Figure 4. The Gata6-PGI2-IL-10 pathway controls IL-1b production in Gata6-WT pMФ.A IL-10 ELISA of supernatants of Gata6-WT and Gata6-KOmye pMФ unstimulated (–) or stimulated with 100 ng/ml LPS. Data shown are representative of at least five
independent experiments.
B, C IL-10 (B) and IL-1b (C) ELISA of supernatants of Gata6-WT and Gata6-KOmye pMФ unstimulated (–) or stimulated with 100 ng/ml LPS, beraprost (1 and 10 lM),
cicaprost (1 and 10 lM), iloprost (1 or 10 nM) or vehicle control (Vh, DMSO). Data shown are representative of at least three independent experiments.
D, E IL-10 (D) and IL-1b (E) ELISA of supernatants of Gata6-WT and Gata6-KOmye pMФ unstimulated (–) or stimulated with 100 ng/ml LPS, 10 lM beraprost, 10 lM
PGE2, 10 lM U46619, 100 lM picotamide or vehicle control (Vh, methyl acetate). Data shown are representative of at least three independent experiments.
F IL-1b ELISA of supernatants of Gata6-WT and Gata6-KOmye pMФ unstimulated (–) or stimulated with 100 ng/ml LPS, 10 ng/ml IL-10, 10 lM beraprost or vehicle
control (Vh). Data shown are representative of at least 3 independent experiments.
G IL-1b ELISA of supernatants of Gata6-WT and Gata6-KOmye pMФ unstimulated (–) or stimulated with 100 ng/ml LPS, 10 lM beraprost, 5 lg/ml aIL-10R or isotype
antibody. Data shown are representative of at least three independent experiments.
H, I IL-1b (H) and IL-10 (I) ELISA of supernatants of Gata6-WT and Gata6-KOmye pMФ unstimulated (–) or stimulated with 100 ng/ml LPS, 10 lM MCC950, 5 lg/ml aIL-
10R or isotype antibody All stimulations were performed for 16 h. Data shown are representative of at least three independent experiments.
J IL-1b ELISA of supernatants of Gata6-WT and Gata6-KOmye pMФ unstimulated (–) or stimulated with 100 ng/ml LPS, 10 ng/ml IL-10 and 5 mM ATP. Data shown
are a pool of three independent experiments.
Data information: Data are expressed as mean  SEM and two-way ANOVA statistical analysis with Tukey’s multiple comparison post-test were performed. *P < 0.05,
**P < 0.01, ***P < 0.001.
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consideration should be taken when modulating the response to
inflammation.
Marketed therapeutics targeting IL-1b are mostly focused on
blocking its receptor (Dinarello et al, 2012) and thereby its signal-
ling. Although proven efficient in reducing symptoms in some
contexts (Cunnane et al, 2001; Bresnihan et al, 2004; Goldbach-
Mansky et al, 2006; Ridker et al, 2017), these drugs do not treat the
cause of aberrant IL-1b production and need to be constantly taken
to prevent overwhelming inflammation. Our work provides insight
into IL-1b regulation, which will be necessary to provide new thera-
peutic options directed to the source of the dysfunction and improve
IL-1b control to ameliorate diseases.
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Figure 5. The aberrant IL-1b production by Gata6-KOmye pMФ is not led by mitochondria dysfunction.
A Flow cytometry analysis of MitoTracker (MT) Green and Red integration in Gata6-WT and Gata6-KOmye naïve pMФ (gated on F4/80hi/+ Tim4+) in vivo, 30 min after
intraperitoneal injection (i.p.) of 1 lM of MitoTracker Green and Red. Data shown are representative of 3–5 independent mice of each genotype and are expressed as
mean  SEM. Student’s t-test analysis was performed.
B Flow cytometry analysis of MitoTracker Green and Red staining in Gata6-WT and Gata6-KOmye pMФ (gated on F4/80hi/+ Tim4+) unstimulated (–) or after LPS
(100 ng/ml), IL-10 (10 ng/ml), aIL-10R (5 lg/ml) or isotype (5 lg/ml) stimulation for 16 h in vitro. Data shown are pooled from three independent experiments and
normalized to WT unstimulated.
C Flow cytometry analysis of MitoSOX staining in Gata6-WT and Gata6-KOmye pMФ (gated on F4/80hi/+ Tim4+) unstimulated (–) or after LPS (100 ng/ml), IL-10
(10 ng/ml) and aIL-10R (5 lg/ml) stimulation for 16 h in vitro. Data shown are pooled from 2 independent experiments and normalized to WT unstimulated.
D IL-1b ELISA of supernatants of Gata6-WT and Gata6-KOmye pMФ unstimulated (–) or stimulated with 100 ng/ml LPS, 500 lM MitoTEMPO, 10 mM NAC, 0.5 lM
MitoQ for 16 h. Data are representative of at least 3 experiments.
Data information: Data are expressed as mean  SEM, and two-way ANOVA statistical analysis with Tukey’s multiple comparison post-test was performed unless
otherwise stated. *P < 0.05, ***P < 0.001.
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Materials and Methods
Mice
Lysozyme M Cre-recombinase “knock-in” congenic mice on the
C57BL/6 background (‘Lyz2Cre, B6.129P2-Lyz2tm1(cre)Ifo/J) and condi-
tional “floxed” Gata6-deficient mice (‘Gata6Fl, Gata6tm2.1Sad/J) were
obtained from the Jackson Labs and bred in our animal facilities as
previously described (Rosas et al, 2014). All mice were sex-matched
and between 6–12 weeks of age at the time of use, unless otherwise
stated. All animal work was conducted in accordance with Institu-
tional and UK Home Office guidelines.
Reagents
Ultra-pure LPS-EB from E. coli O111:B4, Pam3CSK4, Poly(I:C) (HMW),
Flagellin, R848, and CpG ODN 1826 were purchased from InvivoGen.
MitoTEMPO, N-acetyl-L-cysteine, Ac-YVAD-cmk, nigericin, ATP and
picotamide were purchased from Sigma. Beraprost, cicaprost, iloprost,
U46619 and mitoquinone were purchased from Cambridge Bioscience.
PGE2 was purchased from R&D. MCC950 sodium salt was a kind gift
from Prof. Avril Robertson (University of Queensland). Recombinant
IL-1ra was purchased from R&D System. Recombinant IL-10 and TNF
were purchased from PeproTech and the anti-IL-10R Antibody (clone
1B1.3A, Bio X Cell). Etanercept was purchased from Sigma-Aldrich.
GolgiBlock was purchased from BD Biosciences.
Resident peritoneal macrophages (pMΦs) isolation and culture
Resident peritoneal macrophages (pMΦs) were obtained via peri-
toneal lavage with 5 ml lavage solution (PBS (Invitrogen) supple-
mented with 5 mM EDTA and 4% foetal calf serum (FCS)). Lavages
of the same genotype were pooled and resuspended in complete
medium (RPMI 1640 supplemented with 10% FCS, 100 U/ml peni-
cillin, 10 lg/ml streptomycin and 400 lM L-glutamine (Invitrogen)).
Typically, the cells were plated and left to adhere for 3 h at 37°C,
5% CO2 before being washed two times with warm complete
medium and further stimulated as indicated. When needed, cells
were plated on Transwell permeable supports (Corning).
Flow cytometry
The following antibodies were used for flow cytometry analysis:
CD11b (clone M1/70) was purchased from BD Biosciences; MHCII
(clone M5/114.15.2), Tim4 (clone RMT4-54), F4/80 (clone BM8),
Ly6G (clone 1A8) from BioLegend; pro-IL-1b (clone NJTEN3) and
matching isotype control antibody were purchased from eBio-
science. For extracellular staining, cells were collected and resus-
pended in flow cytometry buffer (4% FCS in PBS) containing 4 lg/
ml of Fc receptor blocking antibody 2.4G2 (homemade) for 15 min
on ice. Cells were then stained for 30 min with the indicated anti-
bodies. For intracellular staining, cells were first fixed for 15 min
with 2% paraformaldehyde (PFA) and then permeabilized and
blocked at 4°C for 30 min in permeabilization buffer (0.5% bovine
serum albumin (BSA), 5 mM EDTA, 2 mM NaN3 and 0.5% saponin)
containing 4 lg/ml 2.4G2 blocking antibody (homemade). Cells
were then stained with the indicated antibodies for 1 h at 4°C in
permeabilization buffer. Flow cytometry was performed on Cyan
(Beckman Coulter) or Attune (Thermo Fisher) flow cytometer and
analysed with FlowJo software.
Cytokine measurement
Supernatants were collected at the indicated time points, transferred
to V-bottom 96-well plate and centrifuged at 500 ×g for 5 min. The
supernatant was carefully removed and placed into a fresh 96-well
V-bottom plate (cell-free supernatant). If the supernatants were not
assessed for cytokine production immediately, samples were stored
at 80°C until use. Supernatants were assayed for IL-1b (R&D
Systems), TNF and IL-10 (BD OptEIATM, BD Biosciences) following
the manufacturer’s instructions.
Caspase1 activity measurement
Caspase1 activity was evaluated using the FAM FLICATM Caspase-1
Kit (Bio-Rad), following the manufacturer’s instructions.
Mitochondrial content measurement
MitoTracker Green FM, MitoTracker DeepRed and MitoSOX Red
mitochondrial superoxide indicator were purchased from Thermo
Fisher. In vitro staining was performed following the manufacturer’s
instructions. For in vivo staining, naı¨ve mice were intraperitoneally
(i.p.) injected with 1 lM MitoTracker Green FM or MitoTracker
DeepRed diluted in PBS. Mice were sacrificed 30 min after injection,
and peritoneal cells were collected as described above. The cells
were then stained for cell surface antigens and subsequently anal-
ysed by flow cytometry.
◀ Figure 6. PGI2-derived IL-10 controls IL-1b processing.A mRNA expression analysis of Il1b, Nlrp3 and caspase1 (Casp1) of Gata6-WT and Gata6-KOmye pMФ stimulated for 3 h with 100 ng/ml LPS, 10 lM beraprost, 10 ng/ml
IL-10, 5 lg/ml aIL-10R or 5 lg/ml isotype. Data are representative of at least three independent experiments.
B Western blot analysis (left) and quantification (right) of Gata6-WT and Gata6-KOmye pMФ stimulated for 6 h with 100 ng/ml LPS, 10 lM beraprost, 10 ng/ml IL-10 or
5 lg/ml aIL-10R. Data are representative of three independent experiments.
C Caspase1 activity analysis of Gata6-WT and Gata6-KOmye pMФ stimulated for 16 h with 100 ng/ml LPS, 10 lM beraprost, 10 ng/ml IL-10, 5 lg/ml aIL-10R or 5 lg/ml
isotype. n = 5–8 individual mice.
D Mean fluorescence intensity (MFI) of pro-IL-1b of Gata6-WT and Gata6-KOmye pMФ stimulated for 3 h with 100 ng/ml LPS, 10 lM beraprost, 10 ng/ml IL-10, 5 lg/ml
aIL-10R or 5 lg/ml isotype for 16 h or freshly isolated. n = 6–13 individual mice. Data were log-transformed before performing statistical analysis.
E mRNA expression analysis of Il10 and Tnf of Gata6-WT and Gata6-KOmye pMФ stimulated for 3 h with 100 ng/ml LPS, 10 lM beraprost, 10 ng/ml IL-10 or 5 lg/ml
aIL-10R. Data are representative of at least three independent experiments.
F Representation of the mechanism of action of the Gata6-PGI2-IL-10 active inhibitory signal on IL-1b processing.
Data information: Data are expressed as mean  SEM, and two-way ANOVA statistical analysis with Tukey’s multiple comparison post-test was performed. *P < 0.05,
**P < 0.01, ***P < 0.001.
ª 2020 The Authors The EMBO Journal e103454 | 2020 13 of 17
Natacha Ipseiz et al The EMBO Journal
Immunoblotting
Proteins were isolated using RIPA buffer (Santa Cruz), following
manufacturer’s instructions. Cell-free culture supernatants were
concentrated using methanol/chloroform precipitation. Briefly, one
volume of methanol and one-quarter volume of chloroform were
added to the supernatant, vortexed vigorously for 20 s and then
centrifuged at 20,000× g for 10 min. After centrifugation, the upper
phase was aspirated and one volume of methanol was added,
vortexed for 20 s and centrifuged at 20,000× g for 5 min. The super-
natant was removed, and the pellets briefly dried in a heat block set
at 55°C for 10 min. After drying, the pellet was resuspended in 1 ×
laemmli buffer (Bio-Rad), vortexed and heated to 95°C for 5 min.
Proteins were run on SDS–PAGE gels and transferred to PVDF
membranes (Bio-Rad). The primary antibodies used were goat anti-
mouse IL-1b (catalogue number AF-401-NA; R&D Systems), rat anti-
human/mouse Nlrp3 (clone 768319; R&D Systems), mouse anti-
mouse caspase1 p20 (clone Casper-1; Adipogen), rabbit anti-mouse
ASC (clone AL177, Adipogen), rabbit anti-mouse Ptgis (catalogue
number ab23668, Abcam) and mouse anti-mouse b-actin (clone AC-
74; Sigma). The secondary antibodies used were rabbit anti-goat
(Dako), goat anti-rabbit (Dako), sheep anti-mouse (GE healthcare
life sciences) and rabbit anti-rat (GE healthcare life sciences).
Western blots were quantified using ImageJ.
Quantitative real-time PCR
Total RNA was isolated from cells using RNeasy Mini or Micro Kit
(Qiagen) following the manufacturer’s instructions, and at least
350 ng were reverse transcribed using the High-Capacity cDNA
Reverse Transcription Kit (Applied Biosystems). mRNA levels were
quantified using a ViiATM 7 Real-Time PCR System (Applied Biosys-
tem) and Power SYBR Green PCR Master Mix (Thermo Fisher). The
gene expression values were normalized to Ywhaz expression and
normalized to WT control. The primers used were as followed: Il1b
50-ATGAAGGGCTGCTTCCAAAC-30 and 50-ATGTGCTGCTGCGAGA
TTTG-30; Nlrp3, 50-TGGGCAACAATGATCTTGGC-30 and 50-TTTC
ACCCAACTGTAGGCTCTG-30; Tnf, 50-TAGCCCACGTCGTAGCAAA
C-30 and 50-ACAAGGTACAACCCATCGGC-30; Casp1, 50-CACAGCTC
TGGAGATGGTGA-30 and 50-CTTTCAAGCTTGGGCACTTC-30; Il10,
50-GGTTGCCAAGCCTTATCGGA-30 and 50-GAGAAATCGATGACAG
CGCC-30; Ywhaz 50-TTGAGCAGAAGACGGAAGGT-30 and 50-GAA
GCATTGGGGATCAAGAA-30.
Lipid analysis
Peritoneal lavages of Gata6-WT and Gata6-KOmye mice were
collected. Cells were washed with complete medium and plated for
3 h with or without 100 ng/ml LPS. Supernatants were collected,
snap frozen and stored at 80°C prior to lipid extraction and analy-
sis. Lipids were extracted by adding a 1.25 ml solvent mixture (1 M
acetic acid/isopropanol/hexane; 2:20:30, v/v/v) to 0.5 ml super-
natants in a glass extraction vial and vortexed for 30 s. 1.25 ml
hexane was added to samples and after vortexing for 30 sec., tubes
were centrifuged (500 g for 5 min at 4°C) to recover lipids in the
upper hexane layer (aqueous phase), which was transferred to a
clean tube. Aqueous samples were re-extracted as above by addition
of 1.25 ml hexane. The combined hexane layers were dried in a
RapidVap (Labconco) at 30°C, resuspended in 100 ll methanol and
stored at 80°C. Lipids were then separated on a C18 Spherisorb
ODS2, 5 lm, 150 × 4.6-mm column (Waters) using a gradient of
50–90% B over 20 min (A, water:acetonitrile:acetic acid, 75:25:0.1;
B, methanol:acetonitrile:acetic acid, 60:40:0.1) with a flow rate of
1 ml/min. Products were quantitated by LC/MS/MS electrospray
ionization on an Applied Biosystems 4000 Q-Trap using parent-to-
daughter transitions of m/z 351.2–m/z 271.1 (PGE2), m/z 355.2–m/
z 275.1 (PGE2-d4), m/z 369.2–m/z 169.1 (TXB2), m/z 369.2–m/z
245.1 (6-keto-PGF1a), all [M-H], with collision energies of 20 to
36 V. Source parameters: TEM 650, IS -4500, CUR -35, GS1 60,
GS2 30, EP -10. Products were identified and quantified using PGE2,
6-Keto-PGF1a, TXB2 and PGE2-d4 (10 ng each was added to
samples prior to extraction) standards run in parallel under the
same conditions. Chromatographic peaks were integrated using
Analyst software (Sciex). The criteria for assigning a peak were
signal:noise of at least 3:1 and with at least 7 points across a peak.
The ratio of analyte peak areas to internal standard was taken and
lipids quantified using a standard curve made up and run at the
same time as the samples and the amount of lipids were normalized
to the number of pMФ.
Immunofluorescence
Cells were plated in complete medium on cover glass (VWR, thickness
no. 1) and left to adhere for 3 h before washing 3 times with complete
medium. Following indicated treatment, cells were fixed for 15 min
with 4% PFA and permeabilized and blocked for 30 min with PBS
containing 0.1% Triton X-100 (Sigma), 10% FCS and 10% rabbit
serum. The cells were then stained overnight with the following anti-
body: rabbit anti-mouse ASC (catalogue number AL177, Adipogen)
and F4/80-AF488 (clone BM8, BioLegend). Following washes,
secondary antibody (Goat anti-rabbit-AF594, Thermo Fisher) was
applied for 1 h. DAPI (Thermo Fisher) was applied as counterstain,
and cells were mounted on microscope slides (Thermo Scientific)
using fluorescent mounting medium (Dako). Pictures were taken
using LSM800 confocal laser scanning microscope (Zeiss).
Statistical analysis
Results are expressed as the mean  SEM. Data were analysed with
two-way ANOVA followed by post-tests, unless otherwise stated. A
P < 0.05 was considered statistically significant (*P < 0.05,
**P < 0.01, ***P < 0.001). All statistics were performed using
GraphPad Prism 6 software.
Data availability
Microarray expression data from wild-type and Gata6-deficient
tissue-resident peritoneal macrophages data are available via GEO
(https://www.ncbi.nlm.nih.gov/geo/) (GSE47049).
Expanded View for this article is available online.
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